Principal Scientist, Cell Therapy Translational Biology Research
Bristol Myers Squibb
Summary
The candidate will join the Cellular Therapy Translational Biology Research group in Seattle, WA. Translational Biology is a lab-based research team supporting clinical-stage cell therapy assets, accelerating clinical product development by translating biology into clinical and regulatory decisions. The Principal Scientist will conduct laboratory-based research focused on clinical-stage cellular therapy assets across oncology and autoimmune indications. This includes contributing to mechanism of action studies, drug combination studies, biomarker identification, and generation of data that supports patient stratification, indication selection, and the pharmacodynamic evaluation of therapies in the clinical setting. The successful candidate will be an experienced, self-motivated, and resourceful researcher responsible for driving and implementing non-clinical development strategies across these cell therapy assets.
Job description
Position Responsibilities
- Develop and lead focused research projects, exercising independent judgment in experimental design, execution, and interpretation
- Plan, direct, and execute laboratory research to characterize product/candidate function and inform clinical interpretation and indication strategy
- Design and lead non-clinical/translational data packages to support regulatory submissions and indication expansion for cell therapy programs
- Contribute to biomarker strategy and patient stratification approaches to guide clinical decision-making
- Lead the development, design, and optimization of novel in vitro assays and models to advance translational research objectives
- Investigate the impact of manufacturing and process changes on product functional comparability to support regulatory filings and process decisions
- Represent Translational Biology on cross-functional, multi-disciplinary program/project teams spanning Discovery, Clinical, Regulatory, and Manufacturing
- Contribute to the writing of non-clinical pharmacology study reports, investigator brochures, IND applications, regulatory annual reports, and other regulatory documents when appropriate
- Coordinate external collaborations and/or be the subject matter expert
- Act as a technical point of contact and functional mentor to junior scientists
- Present data and analysis at cross-functional program and team meetings; contribute to conference abstracts, manuscripts, and patent disclosures
- Contribute to lab stewardship initiatives to support productivity, safety, and inspection readiness
Basic Qualifications
- Bachelor’s Degree 8+ years of academic and / or industry experience
- Or Master’s Degree 6+ years of academic and / or industry experience
- Or Ph.D. or equivalent advanced degree in Life Sciences 4+ years of academic and / or industry experience
Preferred Qualifications
- M.S. or Ph.D. in immunology, molecular and cellular biology, or relevant discipline
- M.S. with 6+ years or Ph.D with 4+ years of experience, preferably in the biotechnology or pharmaceutical industry setting, or demonstrated deep experience in immunology or cell therapy academic research
- Expertise in immunology or cellular biology is required, knowledge of fundamentals of oncology and/or autoimmune and inflammatory diseases is desirable
- Familiarity with and experience in the drug development process from IND filing to late stage development in an industry setting is desirable
- Demonstrated ability to independently design, execute, and interpret complex experiments, adapting standard methods and techniques as needed
- Expertise in flow cytometry and cell culture/imaging techniques
- Experience with Incucyte software, JMP and GraphPad prism
- Experience analyzing high content (eg, transcriptomic, proteomic) datasets
- Experience with Electronic Lab Notebooks (ELN) and detailed protocol/process documentation is required
- Excellent communication and interpersonal skills, evidenced by strong ability to interact with and influence research scientists, project teams, and outside collaborators
- Detail-oriented with the ability to identify and implement creative solutions
- Ability to prioritize and manage time efficiently
Requirements
- Bachelor’s Degree with 8+ years of academic and/or industry experience
- Master’s Degree with 6+ years of academic and/or industry experience
- Ph.D. or equivalent advanced degree in Life Sciences with 4+ years of academic and/or industry experience
- Expertise in immunology or cellular biology
- Demonstrated ability to independently design, execute, and interpret complex experiments
- Expertise in flow cytometry and cell culture/imaging techniques
- Experience with Incucyte software, JMP and GraphPad prism
- Experience analyzing high content (e.g., transcriptomic, proteomic) datasets
- Experience with Electronic Lab Notebooks (ELN) and detailed protocol/process documentation
- Excellent communication and interpersonal skills
- Detail-oriented with the ability to identify and implement creative solutions
- Ability to prioritize and manage time efficiently
Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Retirement Benefits
- Flexible Time Off
- 11 Paid Holidays
- Paid Sick Leave
- Volunteer Days
- Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.